Snowball logo
logo
6885

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

688505 SHG
¥8.72-¥0.15  (1.69%)
Start your journey to financial independence
Snowball will help you to track your portfolio, plan deposits to your brokerage account and increase passive income
Start

Frequently asked questions

What sector does Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) operate in?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) current stock price?

As of the latest data, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd stock price is CN¥8.72, with a previous close of CN¥8.87. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd lost -CN¥0.15 in the last trading session, representing a -1.69% loss.

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) current market capitalization?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd market cap is approximately 6.13 billion.

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.04.

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) Price-to-Earnings (P/E) ratio?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd current P/E ratio is 218.

Does Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) pay dividends?

Yes. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd pays semiannual dividends with an annualized yield of 1.03% and an estimated annual payout of CN¥0.09 per share.

When is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) next earnings report?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is expected to release its next earnings report on June 30, 2025.

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) beta (volatility) score?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd has a beta of 0.341, indicating lower volatility than the overall market.